Gene-by-environment interactions in pancreatic cancer: Implications for prevention

Yale Journal of Biology and Medicine

Volumn 88, Issue 2, 2015, Pages 115-126

  Jansen, Rick J ^a   Tan, Xiang Lin ^b,c   Petersen, Gloria M ^d  

^a UNIVERSITY OF CHICAGO   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Genetic polymorphisms; Modifiable risk factors; PC; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; METFORMIN; TUMOR PROTEIN;

ALCOHOL CONSUMPTION; BEHAVIOR MODIFICATION; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; DIETARY INTAKE; EARLY DIAGNOSIS; EPIGENETICS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MARKER GENE; NONHUMAN; OBESITY; PANCREAS CANCER; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SMOKING; TREATMENT PLANNING; COMORBIDITY; DIET; DRINKING BEHAVIOR; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; PANCREATIC NEOPLASMS; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA; TOBACCO USE;

NICOTIANA TABACUM;

ALCOHOL DRINKING; COMORBIDITY; DIET; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; NEOPLASM PROTEINS; OBESITY; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; TOBACCO USE;

EID: 84930162744     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, GLOBOCAN 2008: Cancer incidence and Mortality Worldwide. international Agency for Research on Cancer [internet]. 2010. [accessed 18 Nov 2011]. Available from: http://www.iarc.fr/en/media-centre/iarcnews/2010/globo-can2008.php.
2. Cancer Facts & Figures 2015. American Cancer Society [internet]. Available from: http://www.cancer.org/research/can-cerfactsstatistics/cancerfactsfigures2015/index.
3. Yancik R, Ries LA. Cancer in older persons. Magnitude of the problem--how do we apply what we know? Cancer. 1994;74:1995-2003.
4. Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Al-tekruse S, et al. SeeR Cancer Statistics Review (CSR) 1975-2011. National Cancer institute [internet]. 2014. Available from: http://seer.cancer.gov/csr/1975_2011/.
5. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Flesh-man JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913-21.
6. Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34(4):284-94.
7. Cancer Facts & Figures 2013. American Cancer Society [internet]. 2013. Available from: http://www.cancer.org/re-search/cancerfactsfigures/cancerfactsfigures/cancer-facts-fig ures-2013.
8. Klapman J, Malafa MP. early detection of pancreatic cancer: why, who, and how to screen. Cancer Control. 2008;15(4):280-7.
9. iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008;383(4):535-45.
10. Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, et al. Cigarette smoking and pancreatic cancer: an analysis from the international Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol. 2012;23(7):1880-8.
11. Schulte A, Pandeya N, Tran B, Fawcett J, Fritschi L, Risch HA, et al. Cigarette smoking and pancreatic cancer risk: more to the story than just pack-years. eur J Cancer. 2014;50(5):997-1003.
12. Schenk M, Schwartz AG, O’Neal E, Kinnard M, Greenson JK, Fryzek J P, et al. Familial risk of pancreatic cancer. J Natl Cancer inst. 2001;93(8):640-4.
13. Suwan-ampai P, Navas-Acien A, Strickland PT, Agnew J. involuntary tobacco smoke exposure and urinary levels of polycyclic aromatic hydrocarbons in the United States, 1999 to 2002. Cancer epidemiol Biomarkers Prev. 2009;18(3):884-93.
14. vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, Michaud DS, Severinsen MT, Overvad K, et al. Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the european Prospective investigation into Cancer and Nutrition. int J Cancer. 2010;126(10):2394-403.
15. World Cancer Research Fund/American institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: AiCR; 2007.
16. Stolzenberg-Solomon RZ, Schairer C, Moore S, Hollenbeck A, Silverman DT. Lifetime adiposity and risk of pancreatic cancer in the NiH-AARP Diet and Health Study cohort. Am J Clin Nutr. 2013;98(4):1057-65.
17. Levi A, Kark JD, Afek A, Derazne D, Tzur D, Furman M, et al. Measured body mass index in adolescence and the incidence of pancreatic cancer in a cohort of 720,000 Jewish men. Cancer Causes Control. 2012;23(2):371-8.
18. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. int J Cancer. 2011;129(7):1708-17.
19. Arslan A, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, et al. Anthropomet-ric Measures, Body Mass index, and Pancreatic Cancer. Arch intern Med. 2015;170(9):791-802.
20. vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. int J Obes (Lond). 2006;30(3):400-18.
21. White PB, Ziegler KM, Swartz-Basile DA, Wang SS, Lille-moe KD, Pitt HA, et al. Obesity, but not high-fat diet, promotes murine pancreatic cancer growth. J Gastrointest Surg. 2012;16(9):1680-5.
22. Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrad M, Oberg AL, et al. Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control. 2011;22(12):1613-25.
23. Heinen MM, verhage BA, Goldbohm RA, van den Brandt PA. intake of vegetables, fruits, carotenoids and vitamins C and e and pancreatic cancer risk in The Netherlands Cohort Study. int J Cancer. 2012;130(1):147-58.
24. Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrade M, Oberg AL, et al. Nutrients from Fruit and vegetable Consumption Reduce the Risk of Pancreatic Cancer. J Gastrointest Cancer. 2013;44(2):152-61.
25. Jansen RJ, Robinson DP, Frank RD, Anderson KE, Bamlet WR, Oberg AL, et al. Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study. int J Cancer. 2014;134(8):1935-46.
26. Thiebaut AC, Jiao L, Silverman DT, Cross AJ, Thompson FE, Subar AF, et al. Dietary fatty acids and pancreatic cancer in the NiH-AARP diet and health study. J Natl Cancer inst. 2009;101(14):1001-11.
27. Li D, Day RS, Bondy ML, Sinha R, Nguyen NT, evans DB, et al. Dietary mutagen exposure and risk of pancreatic cancer. Cancer epidemiol Biomarkers Prev. 2007;16(4):655-61.
28. Anderson KE, Mongin SJ, Sinha R, Stolzenberg-Solomon R, Gross MD, Ziegler RG, et al. Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Mol Carcinog. 2012;51(1):128-37.
29. Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, Schairer C, Thompson FE, Kipnis V, et al. Meat and meat-mutagen intake and pancreatic cancer risk in the NiH-AARP cohort. Cancer epidemiol Biomarkers Prev. 2007;16(12):2664-75.
30. Jansen RJ, Robinson DP, Frank RD, Stolzenberg-Solomon RZ, Bamlet WR, Oberg AL, et al. Meat-related mutagens and pancreatic cancer: Null results from a clinic-based case-control study. Cancer epidemiol Biomarkers Prev. 2013;22:1336-9.
31. vrieling A, verhage BA, van Duijnhoven FJ, Jenab M, Over-vad K, Tjonneland A, et al. Fruit and vegetable consumption and pancreatic cancer risk in the european Prospective investigation into Cancer and Nutrition. int J Cancer. 2009;124(8):1926-34.
32. Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA, et al. Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer epidemiol Biomarkers Prev. 2009;18:765-76.
33. Michaud DS, vrieling A, Jiao L, Mendelsohn JB, Steplowski E, Lynch SM, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control. 2010;21(8):1213-25.
34. Tramacere I, Scotti L, Jenab M, Bagnardi V, Bellocco R, Rota M, et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. int J Cancer. 2010;126:1474-86.
35. Cargill M, Altshuler D, ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999;22(3):231-8.
36. Bush WS, Moore JH. Chapter 11: Genome-Wide Association Studies. PLoS Comput Biol. 2012;8(12):e1002822.
37. Marian AJ. Molecular genetic studies of complex pheno-types. Transl Res. 2012;159(2):64-79.
38. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41(9):986-90.
39. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzen-berg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42(3):224-8.
40. Wu C, Miao X, Huang L, Che X, Jiang G, Yu D, et al. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet. 2012;44(1):62-6.
41. Low S-K, Kuchiba A, Zembutsu H, Saito A, Takahashi A, Kubo M, et al. Genome-wide association study of pancreatic cancer in Japanese population. PLoS One. 2010;5(7):e11824.
42. Campa D, Rizzato C, Bauer AS, Werner J, Capurso G, Costello E, et al. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer epidemiol Biomarkers Prev. 2013;22(2):320-3.
43. Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014;46(9):994-1000.
44. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet. 2010;11(4):259-72.
45. engelman CD, Baurley JW, Chiu Y-F, Joubert BR, Lewinger JP, Maenner MJ, et al. Detecting gene-environment interactions in genome-wide association data. Genet epidemiol. 2009;33 Supp 1:S68-73.
46. Chatterjee N, Carroll RJ. Semiparametric maximum likelihood estimation exploiting gene-environment independence in case-control studies. Biometrika. 2005;92:399-418.
47. Mukherjee B, Ahn J, Gruber SB, Ghosh M, Chatterjee N. Case-control studies of gene-environment interaction. Biometrics. 2010;66(3):934-48.
48. Li D, Conti DV. Detecting gene-environment interactions using a combined case-only and case-control approach. Am J epidemiol. 2009;169:497-504.
49. Murcray CE, Lewinger JP, Gauderman WJ. Gene-environment interaction in genome-wide association studies. Am J epidemiol. 2009;169(2):219-26.
50. Bůžková P, Lumley T, Rice K. Permutation and parametric bootstrap tests for gene-gene and gene-environment interactions. Ann Hum Genet. 2011;75(1):36-45.
51. Duell EJ, Holly EA, Bracci PM, Liu M, Wiencke JK, Kelsey KT. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer inst. 2002;94(4):297-306.
52. Liu G, Ghadirian P, vesprini D, Hamel N, Paradis AJ, Lal G, et al. Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma. Br J Cancer. 2000;82:1646-9.
53. Jiao L, Bondy ML, Hassan MM, Chang DZ, Abbruzzese JL, evans DB, et al. Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. Cancer. 2007;109(5):840-8.
54. vrana D, Pikhart H, Mohelnikova-Duchonova B, Holcatova I, Strnad R, Slamova A, et al. The association between glu-tathione S-transferase gene polymorphisms and pancreatic cancer in a central european Slavonic population. Mutat Res. 2009;680:78-81.
55. Bartsch H, Malaveille C, Lowenfels AB, Maisonneuve P, Hautefeuille A, Boyle P. Genetic polymorphism of N-acetyl-transferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The international Pancreatic Disease Study Group. eur J Cancer Prev. 1998;7:215-23.
56. Ayaz L, ercan B, Dirlik M, Atik U, Tamer L. The association between N-acetyltransferase 2 gene polymorphisms and pancreatic cancer. Cell Biochem Funct. 2008;26:329-33.
57. Jiao L, Hassan MM, Bondy ML, Wolff RA, evans DB, Ab-bruzzese JL, et al. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol. 2008;103(2):360-7.
58. Fong P, Fesinmeyer MD, White E, Farin FM, Srinouan-prachanh S, Afsharinejad Z, et al. Association of diabetes susceptibility gene calpain-10 with pancreatic cancer among smokers. J Gastrointest Cancer. 2010;41:203-8.
59. Jang J-H, Cotterchio M, Borgida A, Gallinger S, Cleary SP. Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk. Carcinogenesis. 2012;33(4):818-27.
60. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26:163-75.
61. Suzuki H, Morris JS, Li Y, Doll MA, Hein DW, Liu J, et al. interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Car-cinogenesis. 2008;29(6):1184-91.
62. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer epidemiol Biomarkers Prev. 2000;9(1):29-42.
63. Hirvonen A. Polymorphic NATs and cancer predisposition. iARC Sci Publ. 1999;(148):251-70.
64. Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, evans DB, Li D. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett. 2007;245(1-2):61-8.
65. Affatato AA, Wolfe KJ, Lopez MS, Hallberg C, Ammen-heuser MM, Abdel-Rahman SZ. effect of XPD/eRCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ Mol Mutagen. 2004;44:65-73.
66. Yang M, Sun T, Zhou Y, Wang L, Liu L, Zhang X, et al. The functional cytotoxic T lymphocyte-associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer. Cancer. 2012;118(19):4681-6.
67. Nakao M, Hosono S, ito H, Watanabe M, Mizuno N, Yatabe Y. interaction between iGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. int J Mol epidemiol Genet. 2011;2(4):354-66.
68. Suzuki H, Li Y, Dong X, Hassan MM, Abbruzzese JL, Li D. effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer epidemiol Biomarkers Prev. 2008;17:3467-73.
69. Lin Y, Yagyu K, egawa N, Ueno M, Mori M, Nakao H, et al. An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies. J epidemiol. 2011;21:2-12.
70. Hinney A, Nguyen TT, Scherag A, Friedel S, Brönner G, Müller TD, et al. Genome Wide Association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One. 2007;2(12):e1361.
71. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341-5.
72. Gerken T, Girard CA, Tung Y-CL, Webby CJ, Saudek V, He-witson KS, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318:1469-72.
73. Kloting N, Schleinitz D, Ruschke K, Berndt J, Fasshauer M, Tonjes A, et al. inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia. 2008;51:641-7.
74. Tang H, Dong X, Hassan M, Abbruzzese JL, Li D. Body Mass index and Obesity- and Diabetes-Associated Genotypes and Risk for Pancreatic Cancer. Cancer epidemiol Biomarkers Prev. 2011;20(5):779-92.
75. Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, Tan X, Cunningham JM, et al. Polymorphisms in me-tabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk. Pancreas. 2013;42(7):1043-53.
76. Weydert C, Roling B, Liu JR, Hinkhouse MM, Ritchie JM, Oberley LW, et al. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther. 2003;2:361-9.
77. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, et al. The role of manganese superoxide dis-mutase in the growth of pancreatic adenocarcinoma. Cancer Res. 2003;63(6):1297-303.
78. Ough M, Lewis A, Zhang Y, Hinkhouse MM, Ritchie JM, Oberley LW, et al. inhibition of cell growth by over expression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res. 2004;38(11):1223-33.
79. Yamauchi R. Addition products of alpha-tocopherol with lipid-derived free radicals. vitam Horm. 2007;76:309-27.
80. Hauptmann N, Cadenas E. The oxygen paradox: biochemistry of active oxygen in: Oxidative stress and the molecular biology of antioxidant defenses. Cold Spring Harbor Monograph Archive; 1997. p. 1-20.
81. Tang H, Dong X, Day RS, Hassan MM, Li D. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer. Carcinogenesis. 2010;31(4):607-13.
82. Zhang J, Zhang X, Dhakal IB, Gross MD, Kadlubar FF, Anderson KE. Sequence variants in antioxidant defense and DNA repair genes, dietary antioxidants, and pancreatic cancer risk. int J Mol epidemiol Genet. 2011;2(3):236-44.
83. Baan R, Grosse Y, Straif K, Secretan B, EL Ghissassi F, Bou-vard V, et al. A review of human carcinogens--Part F: chemical agents and related occupations. Lancet Oncol. 2009;10(12):1143-4.
84. Herreros-villanueva M, Hijona E, Bañales JM, Cosme A, Bujanda L. Alcohol consumption on pancreatic diseases. World J Gastroenterol. 2013;19(5):638-47.
85. Shaw S, Jayatilleke E. The role of cellular oxidases and catalytic iron in the pathogenesis of ethanol-induced liver injury. Life Sci. 1992;50:2045-52.
86. ekström G, ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450iie1). Biochem Pharmacol. 1989;38:1313-9.
87. Norton ID, Apte MV, Lux O, Haber PS, Pirola RC, Wilson JS. Chronic ethanol administration causes oxidative stress in the rat pancreas. J Lab Clin Med. 1998;131:442-6.
88. Mohelnikova-Duchonova B, vrana D, Holcatova I, Ryska M, Smerhovsky Z, Soucek P. CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk. Pancreas. 2010;39(2):144-8.
89. verma M. Pancreatic cancer epidemiology. Technol Cancer Res Treat. 2005;4:295-301.
90. Zatonski WA, Boyle P, Przewozniak K, Maisonneuve P, Drosik K, Walker AM. Cigarette smoking, alcohol, tea and coffee consumption and pancreas cancer risk: a case-control study from Opole, Poland. int J Cancer. 1993;53:601-7.
91. Gukovskaya AS, Mouria M, Gukovsky I, Reyes CN, Kasho vN, Faller LD, et al. ethanol metabolism and transcription factor activation in pancreatic acinar cells in rats. Gastroen-terology. 2002;122:106-18.
92. Haber PS, Apte MV, Moran C, Applegate TL, Pirola RC, Ko-rsten MA, et al. Non-oxidative metabolism of ethanol by rat pancreatic acini. Pancreatology. 2004;4:82-9.
93. Dong X, Li Y, Tang H, Chang P, Hess KR, Abbruzzese JL, et al. insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Cancer epidemiol. 2012;36(2):206-11.
94. Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA. CD28 costimulation mediates T cell expansion via iL-2-in-dependent and iL-2-dependent regulation of cell cycle progression. J immunol. 2000;164:144-51.
95. Scheipers P, Reiser H. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. Proc Natl Acad Sci USA. 1998;95:10083-8.
96. etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroen-terology. 2001;120:682-707.
97. Lowenfels AB, Maisonneuve P, DiMagno EP, elitsur Y, Gates LK, Perrault J, et al. Hereditary pancreatitis and the risk of pancreatic cancer. international Hereditary Pancreatitis Study Group. J Natl Cancer inst. 1997;89:442-6.
98. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperpla-sia. Cancer Res. 1994;54:3568-73.
99. Costentin L, Pagès P, Bouisson M, Berthelémy P, Buscail L, escourrou J, et al. Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases. Pancreatology. 2002;2:17-25.
100. vimalachandran D, Ghaneh P, Costello E, Neoptolemos JP. Genetics and Prevention of Pancreatic Cancer. Cancer Control. 2004;11(1):6-14.
101. Li D, Yeung S-CJ, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009;137:482-8.
102. Schneider MB, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding XZ, et al. Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology. 2001;120(5):1263-70.
103. Kisfalvi K, eibl G, Sinnett-Smith J, Rozengurt E. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res. 2009;69:6539-45.
104. Mohammed A, Janakiram NB, Brewer M, Ritchie RL, Marya A, Lightfoot S, et al. Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling. Transl Oncol. 2013;6:649-59.
105. Tan X, Dutta B, Bamlet W, Rabe K, Wang E, Smyrk T, et al. Metformin suppresses pancreatic tumor growth with inhibition of NFB/STAT3 inflammatory signaling. Pancreas. 2014. in Press.
106. Capurso G, Schünemann HJ, Terrenato I, Moretti A, Koch M, Muti P, et al. Meta-analysis: The use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories. Alimentary Pharmacology and Therapeutics. 2007;26(8):1089-99.
107. Larsson SC, Giovannucci E, Bergkvist L, Wolk A. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis. Cancer epidemiol Biomark-ers Prev. 2006;15:2561-4.
108. Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, Meade TW. effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377:31-41.
109. Tan XL, Reid Lombardo KM, Bamlet WR, Oberg AL, Robinson DP, Anderson KE, et al. Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: A clinic-based case-control study. Cancer Prev Res (Phila). 2011;4(11):1835-41.
110. Stan SD, Singh SV, Brand RE. Chemoprevention strategies for pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2010;7:347-56.
111. Zhou H, Huang L, Sun Y, Rigas B. Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling. Cancer Lett. 2009;273:292-9.
112. Rao CV, Mohammed A, Janakiram NB, Li Q, Ritchie RL, Lightfoot S, et al. inhibition of pancreatic intraepithelial neo-plasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice. Neoplasia. 2012;14:778-87.
113. van Kampen JG, Marijnissen-van Zanten MA, Simmer F, van der Graaf WT, Ligtenberg MJ, Nagtegaal ID. epigenetic targeting in pancreatic cancer. Cancer Treat Rev. 2014;40(5):656-64.
114. Truty MJ, Lomberk G, Fernandez-Zapico ME, Urrutia R. Silencing of the transforming growth factor-beta (TGFbeta) receptor ii by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling. J Biol Chem. 2009;284:6291-300.
115. Huang W, Zhao S, Ammanamanchi S, Brattain M, venkata-subbarao K, Freeman JW. Trichostatin A induces transforming growth factor β type ii receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1•NF-Y complex. J Biol Chem. 2005;280:10047-54.
116. Zhao S, venkatasubbarao K, Li S, Freeman JW. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type ii receptor expression in human pancreatic cancer cells. Cancer Res. 2003;63:2624-30.
117. von Burstin J, Eser S, Paul MC, Seidler B, Brandl M, Messer M, et al. e-Cadherin Regulates Metastasis of Pancreatic Cancer in vivo and is Suppressed by a SNAiL/HDAC1/HDAC2 Repressor Complex. Gastroen-terology. 2009;137(1):361-71.
118. Fritsche P, Seidler B, Schüler S, Schnieke A, Göttlicher M, Schmid RM, et al. HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA. Gut. 2009;58:1399-409.
119. Schüler S, Fritsche P, Diersch S, Arlt A, Schmid RM, Saur D, et al. HDAC2 attenuates TRAiL-induced apoptosis of pancreatic cancer cells. Mol Cancer. 2010;9:80.
120. Schuettengruber B, Chourrout D, vervoort M, Leblanc B, Cavalli G. Genome Regulation by Polycomb and Trithorax Proteins. Cell. 2007;128(4):735-45.
121. Tan AC, Jimeno A, Lin SH, Wheelhouse J, Chan F, Solomon A, et al. Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol. 2009;3:425-38.
122. Kuroki T, Tajima Y, Kanematsu T. Role of hypermethyla-tion on carcinogenesis in the pancreas. Surg Today. 2004;34(12):981-6.
123. Heichman KA, Warren JD. DNA methylation biomarkers and their utility for solid cancer diagnostics. Clin Chem Lab Med. 2012;50(10):1707-21.
124. Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, et al. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res. 2009;15(2):740-6.
125. Duell EJ, Bracci PM, Moore JH, Burk RD, Kelsey KT, Holly EA. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer epidemiol Biomarkers Prev. 2008;17(6):1470-9.
126. Zhu B, Tian J, Zhong R, Tian Y, Chen W, Qian J, et al. Genetic variants in the SWi/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population. Mol Carcinog. 2014 Feb 28 [epub ahead of print].
127. Nakao M, Hosono S, Ito H, Watanabe M, Mizuno N, Sato S, et al. Selected polymorphisms of base excision repair genes and pancreatic cancer risk in Japanese. J epidemiol. 2012;22(6):477-83.